MedTrace Logo

The Leisure-time Activity and Nutrition Program

NCT01142206 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2018-04-05

No results posted yet for this study

Summary

The purpose of this investigation is to conduct an 8-week pilot study to examine the effects of two different leisure-time activity prescriptions on dietary intake, leisure-time activities, and weight loss in 30 adults receiving an 8-week behavioral weight loss intervention.

Conditions

Interventions

BEHAVIORAL

Dietary

All participants in the investigation will receive a standard 8-week behavioral obesity intervention with 8 weekly, 1 hour group counseling and education sessions. The intervention will include a reduced caloric prescription (1200-1500 kcal/day) and fat gram prescription (30% or less kcals from fat).

BEHAVIORAL

Physical Activity

All participants will receive a physical activity goal of 200 minutes/week of moderate-intense physical activity.

BEHAVIORAL

TV Watching + Physical Activity

The TV Watching + physical activity arm will receive a TV watching goal of watching less than 10 hours of TV/week.

Sponsors & Collaborators

  • The University of Tennessee, Knoxville

    lead OTHER

Principal Investigators

  • Hollie A Raynor, PhD, RD, LDN · University of Tennessee

  • David Bassett Jr., PhD · University of Tennessee

  • Dixie Thompson, PhD · University of Tennessee

  • Amy Gorin, PhD · University of Connecticut

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01142206 on ClinicalTrials.gov